DHSC creates new NIHR Research Delivery Network
Growing the amount of commercial clinical research will be a key strategic ambition for the new network
The Department of Health and Social Care (DHSC)...
NICE’s draft guidance against use of Vertex therapies may upset new cystic fibrosis patients
Patients who are already using the Vertex therapies can continue to use them, the guideline is open for consultation until 24 November
Modulator therapies,...
Rapid rollout of blood-thinning drugs saves thousands of lives, says NHS
Increased use of direct oral anticoagulants (DOACs) prevented an estimated 17,000 strokes and 4,000 deaths in the last 18 months in England
The National...
Acute migraine? NICE recommends Pfizer’s rimegepant as potential option
The National Institute for Health and Care Excellence (NICE) has released conclusive draft guidance, suggesting Pfizer's Vydura (rimegepant) as a choice for treating acute...
‘Use of biosimilar medicines to treat moderate arthritis is hugely significant milestone’
The National Institute for Health and Care Excellence (NICE)'s decision to recommend the use of biosimilar medicines to treat moderate rheumatoid arthritis is a...